SART3/TIP110 Antibody

SART3 (squamous cell carcinoma antigen recognized by T cells 3) was identified as an antigenic peptide expressed in esophageal cancer cells that is recognized by cytotoxic T lymphocytes. Originally, in a search for a U6 small nuclear RNA capping enzyme, SART3 was identified as a 110kDa nuclear RNA-binding protein. Later, by database searching, SART 3 was determined to also be the human ortholog of the yeast Prp24 snRNP recycling factor that functions in the reassembly of the U4/U6 snRNP during the recycling phase of the splicesome cycle. Recently, SART3-derived peptides have been investigated as candidates for peptide-based immunotherapy in prostate cancer patients due to their ability to induce cytotoxic T lymphocyte activity against prostate cancer cells.
SART3
squamous cell carcinoma antigen recognized by T-cells 3
Squamous cell carcinoma antigen recognized by T-cells 3
:  DSAP1 hSART-3 KIAA0156 P100 p110 p110 nuclear RNA-binding protein p110(nrb) RP11-13G14 SART-3 squamous cell carcinoma antigen recognised by T cells 3 squamous cell carcinoma antigen recognized by T cells 3 tat-interacting protein of 110 kDa TIP110
Product
Specifications
Ordering Information
Human
WB, IP, IHC-P
Between 600 and 650
$339
$229
$99
Human
WB, IP
Between 913 and 963
$339
$229
$99
Human
Includes: 1 each of A301-521A and A301-522A
$472
Includes: 1 each of A301-521A and A301-522A
Human
IHC-P, IF
Between 600 and 650
$360
$99